Lyra Therapeutics
LYRA
#10082
Rank
S$15.93 M
Marketcap
$0.24
Share price
-4.99%
Change (1 day)
-96.77%
Change (1 year)

Operating Margin for Lyra Therapeutics (LYRA)

Operating Margin as of March 2025 (TTM): -4,584.90%

According to Lyra Therapeutics's latest financial reports and stock price the company's current Operating Margin is -4,584.90%. At the end of 2023 the company had an Operating Margin of -4,019.32%.

Operating Margin history for Lyra Therapeutics from 2022 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
2023-4,019.32%-0.87%
2022-4,054.66%-73.44%
2021-15,267.72%
2018-484.65%

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.